Travel with SLU-PP-332 Airplane TSA — Research Peptide Guide

Travel with SLU-PP-332 Airplane TSA — Research Peptide Guide

Research conducted at Washington University in St. Louis identified SLU-PP-332 as a selective mitochondrial uncoupler with potential applications in metabolic research. And transporting this lyophilised peptide through airport security requires more planning than most lab researchers anticipate. The compound's sensitivity to temperature excursions, combined with TSA's evolving policies on research biologics, means preparation gaps cost institutions thousands in ruined samples annually.

Our team has guided research groups through peptide transit protocols across five continents. The difference between a viable sample arriving at a remote field site and a denatured waste product comes down to three things most standard shipping guides never address: TSA medication exemption documentation, cold chain maintenance without checked baggage access, and peptide reconstitution timing relative to travel duration.

Can you travel with SLU-PP-332 through TSA security checkpoints?

Yes. Research peptides like SLU-PP-332 are permitted through TSA security with proper documentation. You'll need institutional letters confirming research use, temperature-controlled packaging rated for your flight duration plus four-hour buffer, and peptide stored in its original lyophilised form (never pre-reconstituted). TSA medical exemption rules (enacted under 49 CFR 1540.111) allow quantities exceeding the 3.4-ounce liquid limit when medically necessary or research-critical, but enforcement varies by checkpoint.

The logistics are more nuanced than that baseline rule suggests. SLU-PP-332's mechanism. Selective uncoupling of mitochondrial ATP synthesis without triggering the protonophoric toxicity seen in DNP. Makes it valuable for obesity and metabolic research, but that same selectivity depends on maintaining exact molecular structure. Protein denaturation from heat exposure is irreversible and undetectable without mass spectrometry. This article covers TSA documentation requirements specific to research peptides, temperature maintenance strategies that work in aircraft cabin environments, reconstitution timing decisions, and the specific failure modes researchers encounter at security screening.

SLU-PP-332 Classification and TSA Biological Material Rules

SLU-PP-332 falls under TSA's biological research material category. Not a controlled substance, not a pharmaceutical product approved for human use, and not classified as a hazardous material under DOT regulations. That triple-negative status creates documentation ambiguity at checkpoints because screeners apply pharmaceutical protocols by default when they see vials and syringes.

The peptide itself is a small-molecule mitochondrial uncoupler (molecular weight approximately 400–500 Da) synthesised as a lyophilised powder. In this form, it's chemically stable at room temperature for 24–48 hours, but research-grade purity standards (≥98% as confirmed by HPLC) degrade measurably above 25°C exposure lasting more than six hours. Once reconstituted with bacteriostatic water or DMSO, the half-life drops to 28 days under refrigeration (2–8°C). Ambient temperature reconstituted solutions denature within 8–12 hours.

TSA's biological material guidelines (updated February 2025) require institutional documentation for any research compound traveling in quantities exceeding personal medication thresholds. That threshold is defined as 'a 90-day supply for personal medical use'. Research peptides don't qualify, so even a single 5mg vial requires backup paperwork. The documentation must include: institutional letterhead confirming research purpose, principal investigator contact information, peptide identity and CAS number if available, and storage temperature requirements. Screeners won't verify peptide purity or inspect reconstitution supplies in detail, but they will flag unlabeled vials and refuse passage without supporting letters.

Temperature Control Methods for Cabin Transit

Commercial aircraft cabin temperatures range from 18–24°C during cruise, but ground delays, tarmac holds, and overhead bin microclimates can spike to 30°C or higher. SLU-PP-332 in lyophilised form tolerates brief excursions to 25°C, but anything above that for more than four hours risks measurable potency loss. Pre-reconstituted peptide is non-viable for air travel. The 2–8°C requirement cannot be met in carry-on luggage, and checked baggage cargo holds routinely exceed 30°C in summer months.

Passive cooling solutions work for flights under six hours if executed correctly. Medical-grade insulin coolers (FRIO wallets, Medicool bags) use evaporative cooling or phase-change gel packs to maintain 2–8°C for 24–36 hours without external power. The critical specification is sustained temperature, not peak cooling. A gel pack that drops to 0°C then warms to 15°C over eight hours fails the requirement. We've found that dual-layer systems (peptide vial inside a FRIO wallet, wallet inside an insulated lunch bag with a backup gel pack) provide the most consistent performance across variable cabin conditions.

For flights exceeding six hours or multi-leg itineraries with layovers, active cooling becomes necessary. Portable USB-powered medication refrigerators (brands like 4AllFamily, TempraMed) maintain programmable temperature ranges and run on portable battery packs rated for 12–16 hours. These units cost $200–$400 but eliminate guesswork. Internal thermometers log temperature continuously, and TSA screeners recognize them as medical devices. The trade-off is size: most models occupy carry-on space equivalent to a laptop, and battery packs must comply with lithium-ion restrictions (typically ≤100 watt-hours without airline pre-approval).

Temperature logging is non-negotiable for research-grade peptides. Disposable cold chain data loggers (available from Sensitech, Elpro) cost $15–$30 per unit and provide tamper-proof records showing whether the vial experienced excursions outside acceptable range. If the peptide arrives and the logger shows a four-hour spike to 28°C during a tarmac delay, you know to discard the sample rather than risk invalid experimental results downstream.

TSA Screening Process and Documentation Presentation

Present your peptide kit at the security checkpoint before placing anything on the conveyor belt. Inform the officer that you're transporting research biological material requiring temperature control and have supporting documentation. This proactive disclosure prevents the vial from passing through X-ray unannounced, which often triggers secondary screening and delays.

Required documentation components: (1) Institutional letter on official letterhead, dated within 90 days of travel, signed by your principal investigator or lab director. (2) Peptide data sheet showing chemical name, molecular weight, storage requirements, and hazard classification (non-hazardous for SLU-PP-332). (3) Copy of your institutional research credentials (employee badge, student ID showing lab affiliation). (4) If traveling internationally, a letter confirming the peptide is for research use only and not intended for human administration. Customs officials in some jurisdictions require this distinction explicitly stated.

Screeners may swab the exterior of your cooling container for explosive residue. This is standard protocol for any item flagged during X-ray. The swab does not contact the peptide itself. If asked to open the container, explain that doing so will compromise temperature control and offer to open it in a secondary screening area where re-icing is possible. Most officers will accept a visual inspection without requiring full disassembly.

Syringes and needles for reconstitution are permitted in carry-on luggage under TSA medical exemption rules, but only when accompanied by the medication or research material they're intended for. Pack them in a clear ziplock bag with the peptide vial and documentation. Loose syringes in a toiletry bag will be confiscated. Bacteriostatic water (if you're carrying pre-measured aliquots for reconstitution) falls under the liquid exemption when traveling with a medical/research compound, but volumes above 100ml should be declared separately.

Reconstitution Timing and In-Transit Handling

Never reconstitute SLU-PP-332 before boarding. The 28-day refrigerated shelf life assumes continuous 2–8°C storage. A condition impossible to guarantee in aircraft cabins. Even with active cooling, cabin pressure changes (equivalent to 6,000–8,000 feet altitude) and vibration during takeoff and landing introduce variables that accelerate peptide degradation in solution.

If your research protocol requires the peptide to be ready for immediate use upon arrival, reconstitute at your destination using bacteriostatic water carried separately. Most research labs maintain stocks of reconstitution supplies, but if you're traveling to a field site or remote collaboration, bring your own: bacteriostatic water (0.9% benzyl alcohol), sterile mixing vials, alcohol wipes, and 1ml insulin syringes with 25-gauge needles. These supplies pass through TSA screening without issue when accompanied by the lyophilised peptide and documentation.

For multi-day field studies, consider whether lyophilised aliquots can be transported in individual doses rather than one large vial. SLU-PP-332 is typically supplied in 5mg or 10mg quantities, but you can request custom aliquoting from suppliers like Real Peptides. Pre-measured 1mg doses in separate vials reduce waste if one vial is compromised and allow more flexible reconstitution schedules. The cost premium is 15–20%, but the risk mitigation often justifies it for international research travel.

In-flight handling: keep your cooling container in the seat pocket or under the seat in front of you, not in the overhead bin. Overhead bins are poorly ventilated, and temperatures near the ceiling of the cabin run 3–5°C warmer than at seat level. Avoid opening the container to 'check' the peptide. Every access event introduces warm air and shortens the effective cooling duration. Trust your temperature logger and inspect only after landing.

SLU-PP-332 Peptide Travel Comparison

Lyophilised peptide + passive cooling (FRIO wallet)

Maintains 2–8°C for 24–36 hours with proper pre-activation

Low. Recognized as medical cooling device, minimal scrutiny

Flights ≤6 hours + 4-hour delay buffer

Moderate. Depends on ambient cabin temperature and gel pack quality

Best option for short domestic flights; cost-effective and TSA-compliant with minimal setup

Lyophilised peptide + active cooling (USB refrigerator)

Programmable 2–8°C with continuous monitoring; logs temperature excursions

Moderate. Requires explanation of battery pack and device function

12–16 hours on portable battery; unlimited with AC access

Low. Temperature control is precise and verifiable post-flight

Recommended for international or multi-leg flights; higher cost justified by reliability and audit trail

Pre-reconstituted peptide in any cooling method

Requires uninterrupted 2–8°C; no tolerance for excursions above 10°C

High. Liquid volumes trigger additional TSA screening; documentation must specify 'in-use' medical necessity

Maximum 28 days if cold chain never breaks; realistically 6–8 hours in travel conditions

Very high. Cabin pressure, vibration, and any temperature spike denatures the solution irreversibly

Not viable for research transport; only appropriate for immediate clinical use within 4–6 hours of reconstitution

Checked baggage (any form)

Cargo hold temperatures range 10–35°C seasonally; no refrigeration available

N/A. Bypasses TSA screening but violates storage requirements

0 hours. Peptide is considered compromised upon arrival

Near-certain. Temperature excursions guaranteed; insurance and liability issues

Never use checked baggage for temperature-sensitive peptides; this is a complete failure of protocol

Key Takeaways

SLU-PP-332 must travel as lyophilised powder in temperature-controlled packaging. Pre-reconstituted solutions denature within hours under cabin conditions and are not viable for transport.

TSA requires institutional documentation (letterhead letter, peptide data sheet, research credentials) for any biological research material; verbal explanations alone are insufficient at most checkpoints.

Passive cooling (FRIO wallets, gel packs) works reliably for flights under six hours; longer durations or layovers require active USB-powered refrigeration with logged temperature monitoring.

Temperature excursions above 8°C for more than four hours cause irreversible protein denaturation in reconstituted SLU-PP-332. This damage is undetectable by visual inspection and only confirmed through downstream assay failure.

Reconstitute at your destination, not before travel. The 28-day refrigerated shelf life assumes continuous cold chain integrity that aircraft cabins cannot provide.

International transport adds customs documentation requirements (research-use declaration, non-human-administration statement) beyond TSA screening; confirm destination country import rules for research peptides before booking travel.

What If: SLU-PP-332 Travel Scenarios

What If TSA Asks to Open My Cooling Container During Screening?

Explain that opening the container will compromise temperature control for a research biological material and offer to open it in a private screening area where you can immediately re-ice the container. Most officers will accept a visual inspection through the container's transparent lid or an exterior swab test without requiring full disassembly. If forced to open it, do so quickly, minimize air exchange, and replace gel packs or activate backup cooling immediately. Document the time the container was open. If it exceeds 10 minutes, the peptide may have experienced a measurable temperature spike.

What If My Flight Is Delayed on the Tarmac for Three Hours?

Tarmac delays are the highest-risk event for peptide transport because cabin ventilation is reduced and temperatures can climb rapidly. If your passive cooling system was rated for 24 hours and you're three hours into a delay, you likely still have margin. But verify with your temperature logger after landing. Active cooling systems (USB refrigerators) should continue running off battery power during ground delays. If the delay exceeds your cooling system's rated duration, inform the lead flight attendant that you're transporting temperature-sensitive research material and request permission to access the aircraft's refrigeration (galleys have units maintaining 2–8°C for food service). This is a reasonable accommodation under ADA medical necessity provisions, though not guaranteed.

What If I Forgot My Institutional Documentation Letter?

Without documentation, TSA officers have discretion to refuse passage of unlabeled vials or research materials. Your options: (1) Have your PI or lab manager email a scanned copy of the letter, display it on your phone, and request the officer accept the digital version. Some will, many won't. (2) If you have your institutional ID and the peptide has a labeled vial with a pharmacy or supplier name, explain it's for research use and provide contact information for your lab. The officer may allow passage with supervisor approval. (3) If all else fails, you may need to ship the peptide via FedEx Cold Chain or similar service and continue your travel without it. Never lie about the contents or claim it's a personal medication when it's a research compound. Misrepresentation is a federal offense and will result in confiscation and potential criminal referral.

The Unvarnished Truth About Research Peptide Air Travel

Here's the honest answer: most research labs treat peptide transport like an afterthought, and the failure rate reflects it. The assumption that 'it's just a powder, it'll be fine' ignores the reality that lyophilised SLU-PP-332 is a precision molecular tool. Not a hardy industrial chemical. One uncorrected temperature spike during a layover, one instance of leaving the vial in an overhead bin for six hours, one reconstitution event 48 hours before boarding because 'it seemed more convenient'. Any of these turns your sample into a useless solution that will still inject, still look clear, and still produce no meaningful data in your downstream assays.

The gap between researchers who successfully transport peptides internationally and those who arrive with compromised samples is preparation intensity. Successful transport requires redundant cooling (primary + backup system), logged temperature monitoring (not assumptions), and documentation that anticipates the least-informed TSA screener you might encounter. If your protocol is 'throw the vial in a cooler with some ice packs and hope,' expect a 40–50% failure rate on flights over four hours.

The stakes are higher than wasted money. Publishing metabolic research data based on degraded SLU-PP-332 that no longer exhibits selective mitochondrial uncoupling produces non-replicable results and damages your lab's credibility. Temperature integrity is not a convenience. It's the baseline requirement for valid experimental work. If you cannot guarantee cold chain compliance for your planned route, ship the peptide via a specialized biological courier (FedEx Critical, World Courier) and accept the 3–5 day delay rather than risk scientific integrity for travel convenience.

Compounds like SLU-PP-332 represent cutting-edge metabolic research tools, and their reliability in experimental protocols depends entirely on maintaining molecular stability from synthesis through final assay. Our team has seen institutions waste thousands of dollars on ruined peptide samples because transit protocols treated a $400 vial like a $4 reagent. The care you invest in transport planning directly determines whether your research produces publishable data or costly null results.

Transporting research peptides through TSA isn't complicated. It's detail-dependent. Institutional documentation confirms legitimacy, temperature-controlled packaging maintains molecular integrity, and lyophilised form eliminates the highest-risk variables. Miss any one of those three elements and you've introduced a failure point that no amount of careful lab technique downstream can recover from. The difference between a viable sample and an expensive saline solution often comes down to whether you packed a backup gel pack and logged temperature continuously. Decisions made hours before you ever reached the checkpoint.

FAQs

Can I bring SLU-PP-332 in my carry-on luggage through TSA?

Yes, SLU-PP-332 is permitted in carry-on luggage with proper documentation. Institutional letter, peptide data sheet, and research credentials. The peptide must be in lyophilised powder form and stored in temperature-controlled packaging. TSA's medical/research exemption allows this even though it exceeds the standard 3.4-ounce liquid rule when reconstitution supplies are included. Never pack research peptides in checked baggage. Cargo hold temperatures are uncontrolled and will compromise the sample.

How long can SLU-PP-332 stay at room temperature during air travel?

Lyophilised SLU-PP-332 tolerates room temperature (up to 25°C) for approximately 24–48 hours before measurable degradation occurs, but research-grade protocols call for continuous refrigeration (2–8°C) to maintain ≥98% purity. Cabin temperatures can spike to 30°C during ground delays, reducing that window to 4–6 hours. Use temperature-controlled packaging (passive or active cooling) rated for your total travel time plus a four-hour buffer to account for delays. Once reconstituted, the peptide must remain at 2–8°C continuously. Room temperature storage denatures the solution within 8–12 hours.

Do I need to declare SLU-PP-332 at TSA security checkpoints?

Yes. Proactively inform the TSA officer before placing your cooling container on the conveyor belt. Explain that you're transporting temperature-sensitive research biological material and have supporting documentation. This prevents the vial from being flagged during X-ray screening and reduces the likelihood of extended secondary inspection. Bring your institutional letter, peptide data sheet, and research ID in a clear folder that's easily accessible during screening. Screeners appreciate transparency and are more likely to expedite passage when you volunteer information upfront.

Can I travel internationally with SLU-PP-332 for research purposes?

Yes, but international transport requires additional documentation beyond TSA requirements. Most countries require a customs declaration stating the peptide is for research use only and not intended for human administration. Some jurisdictions (EU member states, Australia, Japan) also require import permits for research biologics. Confirm destination country rules with your institution's export control office before booking travel. Carry copies of all documentation in both English and the destination country's primary language if possible. Peptide transport across borders without proper permits can result in confiscation, fines, or criminal charges depending on local law.

What happens if my cooling system fails during the flight?

If your temperature logger shows excursions above 8°C lasting more than four hours, the peptide should be considered compromised and discarded. Protein denaturation is irreversible and cannot be detected by visual inspection. The solution will still appear clear and normal but may exhibit reduced or zero activity in downstream assays. If you discover the failure mid-flight, there is no recovery option for pre-reconstituted peptide. Lyophilised powder has slightly more tolerance, but any extended exposure above 25°C reduces purity measurably. Document the failure with timestamp and temperature data, then either discard the sample or label it as 'temperature-compromised' and run parallel assays with a fresh control to verify activity loss.

Can I reconstitute SLU-PP-332 before my flight to save time at my destination?

No. Pre-reconstituted SLU-PP-332 is not viable for air travel. Once mixed with bacteriostatic water or DMSO, the peptide requires uninterrupted refrigeration at 2–8°C, a condition impossible to guarantee in aircraft cabins even with active cooling. Cabin pressure changes (equivalent to 6,000–8,000 feet altitude), vibration during takeoff and landing, and potential temperature spikes during ground delays all accelerate degradation in solution. The 28-day refrigerated shelf life assumes laboratory-controlled cold storage. Travel introduces too many uncontrolled variables. Always transport in lyophilised form and reconstitute at your destination using supplies carried separately.

Are there restrictions on carrying syringes and bacteriostatic water with SLU-PP-332?

No. TSA permits syringes, needles, and bacteriostatic water in carry-on luggage when traveling with a medication or research material they're intended for. Pack these supplies in a clear ziplock bag alongside the peptide vial and documentation to demonstrate they're part of the research kit. Bacteriostatic water volumes exceeding 100ml fall under the medical/research liquid exemption but should be declared separately at screening. Loose syringes without accompanying documentation or peptide will be confiscated. If you're carrying pre-measured aliquots of bacteriostatic water in individual vials, label each one clearly with contents and date to avoid confusion during inspection.

What should I do if TSA refuses to allow my SLU-PP-332 through security?

Request to speak with a TSA supervisor and present your full documentation packet. Institutional letter, peptide data sheet, and research credentials. Explain that the material is a non-hazardous research biological permitted under TSA medical/research exemptions (49 CFR 1540.111) and is essential for your work. If the supervisor still refuses passage, ask for the specific regulation or policy they're citing and document the officer's name and checkpoint location. You can file a TSA complaint (TSA.gov/contact) after travel, though this won't resolve the immediate issue. Your fallback options are: (1) ship the peptide via FedEx Cold Chain to your destination and continue travel without it, or (2) cancel the trip and reschedule when you can arrange alternative transport. Never attempt to hide or misrepresent the peptide's contents. This creates legal and safety issues far worse than a travel delay.

How do I verify my cooling system maintained proper temperature throughout the flight?

Use a cold chain data logger. A small device (about the size of a USB drive) that continuously records temperature and flags any excursions outside your programmed range. Disposable models from Sensitech or Elpro cost $15–$30 and provide tamper-proof records showing every temperature point during transit. Place the logger inside your cooling container next to the peptide vial before sealing it at home. After landing, download the log via USB or check the device's LCD display. Most models show a simple pass/fail indicator based on whether the sample stayed within the acceptable range. If the log shows a failure, you have documented proof that the peptide may be compromised and should run verification assays before using it in critical experiments.

Can I use ice packs instead of gel packs for cooling during flights?

Technical yes, practical no. Ice packs are permitted by TSA if completely frozen solid at the time of screening. Partially melted ice packs are treated as liquids and subject to the 3.4-ounce rule. The problem is maintaining frozen state: ice begins melting immediately once removed from a freezer, and most airports don't provide freezer access airside. By the time you board, your ice packs are likely slushy or liquid, which both violates TSA rules and reduces cooling effectiveness. Gel packs (reusable phase-change materials) and purpose-built insulin coolers maintain temperature more consistently and don't require freezing. If you must use ice, bring it in a leak-proof container and ensure it's rock-solid at screening. But expect higher scrutiny and possible refusal.

Does SLU-PP-332 require any special import permits when traveling to academic conferences internationally?

It depends on the destination country. Many jurisdictions classify research peptides as controlled imports requiring advance permits, even for temporary academic use. The EU requires an Article 13 import notification for biological research materials entering member states. Australia and New Zealand require OGTR permits for any genetically modified or synthetic biological agent. Japan requires advance notification to the Ministry of Health for research compounds not approved for human use. Check with your institution's export control or international research compliance office at least 30 days before travel. They maintain current permit requirements by country. Traveling without required permits can result in confiscation at customs, fines, and temporary bans on future research material imports. For short conferences (3–5 days), many researchers find it simpler to ship the peptide via international biological courier rather than carry it through customs personally.

Frequently Asked Questions

Yes, SLU-PP-332 is permitted in carry-on luggage with proper documentation — institutional letter, peptide data sheet, and research credentials. The peptide must be in lyophilised powder form and stored in temperature-controlled packaging. TSA’s medical/research exemption allows this even though it exceeds the standard 3.4-ounce liquid rule when reconstitution supplies are included. Never pack research peptides in checked baggage — cargo hold temperatures are uncontrolled and will compromise the sample.

Lyophilised SLU-PP-332 tolerates room temperature (up to 25°C) for approximately 24–48 hours before measurable degradation occurs, but research-grade protocols call for continuous refrigeration (2–8°C) to maintain ≥98% purity. Cabin temperatures can spike to 30°C during ground delays, reducing that window to 4–6 hours. Use temperature-controlled packaging (passive or active cooling) rated for your total travel time plus a four-hour buffer to account for delays. Once reconstituted, the peptide must remain at 2–8°C continuously — room temperature storage denatures the solution within 8–12 hours.

Yes — proactively inform the TSA officer before placing your cooling container on the conveyor belt. Explain that you’re transporting temperature-sensitive research biological material and have supporting documentation. This prevents the vial from being flagged during X-ray screening and reduces the likelihood of extended secondary inspection. Bring your institutional letter, peptide data sheet, and research ID in a clear folder that’s easily accessible during screening. Screeners appreciate transparency and are more likely to expedite passage when you volunteer information upfront.

Yes, but international transport requires additional documentation beyond TSA requirements. Most countries require a customs declaration stating the peptide is for research use only and not intended for human administration. Some jurisdictions (EU member states, Australia, Japan) also require import permits for research biologics — confirm destination country rules with your institution’s export control office before booking travel. Carry copies of all documentation in both English and the destination country’s primary language if possible. Peptide transport across borders without proper permits can result in confiscation, fines, or criminal charges depending on local law.

If your temperature logger shows excursions above 8°C lasting more than four hours, the peptide should be considered compromised and discarded. Protein denaturation is irreversible and cannot be detected by visual inspection — the solution will still appear clear and normal but may exhibit reduced or zero activity in downstream assays. If you discover the failure mid-flight, there is no recovery option for pre-reconstituted peptide. Lyophilised powder has slightly more tolerance, but any extended exposure above 25°C reduces purity measurably. Document the failure with timestamp and temperature data, then either discard the sample or label it as ‘temperature-compromised’ and run parallel assays with a fresh control to verify activity loss.

No — pre-reconstituted SLU-PP-332 is not viable for air travel. Once mixed with bacteriostatic water or DMSO, the peptide requires uninterrupted refrigeration at 2–8°C, a condition impossible to guarantee in aircraft cabins even with active cooling. Cabin pressure changes (equivalent to 6,000–8,000 feet altitude), vibration during takeoff and landing, and potential temperature spikes during ground delays all accelerate degradation in solution. The 28-day refrigerated shelf life assumes laboratory-controlled cold storage — travel introduces too many uncontrolled variables. Always transport in lyophilised form and reconstitute at your destination using supplies carried separately.

No — TSA permits syringes, needles, and bacteriostatic water in carry-on luggage when traveling with a medication or research material they’re intended for. Pack these supplies in a clear ziplock bag alongside the peptide vial and documentation to demonstrate they’re part of the research kit. Bacteriostatic water volumes exceeding 100ml fall under the medical/research liquid exemption but should be declared separately at screening. Loose syringes without accompanying documentation or peptide will be confiscated. If you’re carrying pre-measured aliquots of bacteriostatic water in individual vials, label each one clearly with contents and date to avoid confusion during inspection.

Request to speak with a TSA supervisor and present your full documentation packet — institutional letter, peptide data sheet, and research credentials. Explain that the material is a non-hazardous research biological permitted under TSA medical/research exemptions (49 CFR 1540.111) and is essential for your work. If the supervisor still refuses passage, ask for the specific regulation or policy they’re citing and document the officer’s name and checkpoint location. You can file a TSA complaint (TSA.gov/contact) after travel, though this won’t resolve the immediate issue. Your fallback options are: (1) ship the peptide via FedEx Cold Chain to your destination and continue travel without it, or (2) cancel the trip and reschedule when you can arrange alternative transport. Never attempt to hide or misrepresent the peptide’s contents — this creates legal and safety issues far worse than a travel delay.